Navigation Links
FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
Date:6/20/2008

s 8%), bone pain (11% vs 10%), arthralgia (11% vs 15%) and pruritus (10% vs 5%).

Important Safety Information

In the U.S., VELCADE is indicated for the treatment of patients with multiple myeloma. VELCADE also is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. VELCADE is contraindicated in patients with hypersensitivity to bortezomib, boron or mannitol. VELCADE should be administered under the supervision of a physician experienced in the use of antineoplastic therapy.

Risks associated with VELCADE therapy include new or worsening peripheral neuropathy, hypotension throughout therapy, cardiac and pulmonary disorders, reversible posterior leukoencephalopathy syndrome, gastrointestinal adverse events, thrombocytopenia, neutropenia, tumor lysis syndrome and hepatic events. Women of childbearing potential should avoid becoming pregnant while being treated with VELCADE. Nursing mothers are advised not to breastfeed while receiving VELCADE. Cases of severe sensory and motor peripheral neuropathy have been reported. The long-term outcome of peripheral neuropathy has not been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and new onset of decreased left ventricular ejection fraction has been reported, including reports in patients with no risk factors for decreased left ventricular ejection fraction. There have been reports of acute diffuse infiltrative pulmonary disease of unknown etiology such as pneumonitis, interstitial pneumonia, lung infiltration and Acute Respiratory Distress Syndrome in patients receiving VELCADE. Some of these events have been fatal. There have been reports of Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological d
'/>"/>

SOURCE Millennium Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Japan Approves CyberKnife System for Extracranial Use
2. FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients
3. FDA Approves Cymbalta(R) for the Management of Fibromyalgia
4. ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobaccos Harm
5. FDA Approves AstraZenecas Seroquel(R) for Maintenance Treatment in Bipolar Disorder
6. FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
7. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
8. FDA Approves Health Claim for Brown Rice
9. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
10. FDA approves HeartMate II mechanical heart pump for heart-failure patients
11. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... ... 05, 2015 , ... Stelari introduces their new collection, The Earth’s Song, inspired ... line, The Earth’s Song. Combining fashion and activewear, Stelari’s new collection let’s you take ... Australian Outback, this collection is sure to make the spirit seeker swoon with prints ...
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... ... critical research funding, as well as awareness, education and support in order to ... Brain Aneurysm Foundation proudly announces this year it has awarded the most ...
(Date:8/4/2015)... ... ... MONTICELLO, Fla. – After completing 2,400 hours in the Clinical Pastoral Education Programs ... clinician allowed Dr. Barbara Thomas-Reddick to gain the skills and the know-how ... friends and staff, and she was able to witness after leaving the patients’ bedside, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Statement by ... applauds the introduction of the Mental Health Reform Act of 2015 by ... comprehensive mental health reform a reality in America. , “This legislation and ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... uses Cloud innovation to consolidate oncology patient assistance programs. Through a secure web ... of access. assistPoint is an enterprise level, cloud-based application and workflow solution. This ...
Breaking Medicine News(10 mins):Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 2Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 3Health News:Brain Aneurysm Foundation Awards Largest Amount of Research Funding at 9th Annual Brain Aneurysm Foundation Research Grant Awards Symposium Sept 10th in Houston, Texas 4Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 2Health News:New book shows how ‘The Presence of a Chaplain’ affects lives 3Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:assistPoint.com Web Site Launched 2
... , ... a company dedicated to disseminating information on dentistry,s role in the recognition and management of ... web site for the second month in a row. , ... New York, NY (PRWEB) July 31, 2009 -- Snoring Isn,t ...
... , WHITE PLAINS, N.Y., July 30 The ... University of Chicago, a pioneer in demonstrating that cancer is a ... President Barack Obama will award the Medals of Freedom, the nation,s ... Aug. 12, 2009. , , Dr. Rowley is ...
... , , , ... and Consumer Product Safety, The Pew Charitable Trusts: , , ... and strengthen the nation,s food safety system. This historic action takes a ... of their food. , , "Foodborne disease kills one ...
... Calls on Senate to Follow Suit , , ... commended the members of the United States House of Representatives for passing ... passed the House by a vote of 283-142. , , ... an important milestone," said Ms. Bailey. "This legislation will strengthen our ...
... , BOISE, Idaho, July 30 ... named John Stellmon, president of Regence BlueShield of Idaho, to ... In his new expanded role, effective August 1, ... health management programs. He will also oversee Pharmacy Services, Network ...
... implemented, expert says , THURSDAY, July 30 (HealthDay ... lead to reduced use of palliative care, Belgian researchers ... Group in Brussels also found that dying patients who ... life were more likely to choose euthanasia or physician-assisted ...
Cached Medicine News:Health News:SnoringIsntSexy.com Tops 21,000 Site Visits for Second Month in a Row 2Health News:Janet Rowley, MD, A Researcher Funded by The Leukemia & Lymphoma Society, Receives Presidential Medal of Freedom 2Health News:GMA Applauds U.S. House for Passage of Landmark Food Safety Bill 2Health News:Regence BlueShield of Idaho Announces Executive Changes 2Health News:Regence BlueShield of Idaho Announces Executive Changes 3Health News:Euthanasia, Palliative Care Work in Unison in Belgium 2
(Date:8/4/2015)... Aug. 4, 2015  Dr. Keesha Ewers ... potential FDA approval of flibanserin, or what is ... the treatment of decreased female sexual desire back ... root causes and addressing libido as a singular ... Photo ...
(Date:8/4/2015)... -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) today reported ... the three and six months ended June 30, 2015, ... and $43.4 million for the same periods in 2014. ... the more than $90 million of revenue Isis earned ... from Bayer to license  ISIS-FXI Rx .  Isis increased ...
(Date:8/4/2015)... , Aug. 4, 2015  Intec Pharma Ltd. (the ... company focused on developing drugs based on its proprietary ... its initial public offering in the United ... at a price to the public of $6.00 per ... the ordinary shares are being offered by the Company.  ...
Breaking Medicine Technology:Potential FDA Approval of "Pink Viagra" Sends Wrong Message 2Potential FDA Approval of "Pink Viagra" Sends Wrong Message 3Potential FDA Approval of "Pink Viagra" Sends Wrong Message 4Potential FDA Approval of "Pink Viagra" Sends Wrong Message 5Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 2Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 3
... authorization for prescription medications is a time-consuming process for ... faxes and hard-copy request forms. While some on-line solutions ... solution and one that is integrated with available e-prescribing ... in the marketplace, CVS Caremark (NYSE: CVS ...
... 2011 Relying on a proven partnership, ... Software Systems ChartSmart® Electronic Medical Records as ... toward improved clinical care which will also ... guidelines in order to qualify for federal ...
Cached Medicine Technology:CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 2CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication 3Sharkey Issaquena Community Hospital Implements ChartSmart emr® 2Sharkey Issaquena Community Hospital Implements ChartSmart emr® 3
... loupes are ideal for general dental ... and a large field of view ... aligned, lightweight and comfortable to wear ... and superior depth of focus means ...
23 gauge thin wall irrigation. 25 gauge thin wall aspiration. Angled 30 degree shaft 8 mm from tip to bend. Irrigation tip set 0.5 mm behind aspiration tip. Dual hub construction. Polished finish. Ov...
23 gauge cannula (E4969 L) with 0.33 mm aspiration port, curved shaft and polished finish. Includes Teflon irrigating sleeve (E4969 SL). Uses 60 cm (23.6 inches) of silicone tubing (N5941 5). Overall...
... come with five legs for extra stability. ... (total vertical travel 6"). 2" ball bearing ... fire retardant upholstery, available in black vinyl ... order. Top of the range pneumatic stool ...
Medicine Products: